atypical chronic myeloid leukemia, BCR-ABL1 negative

Summary
Synonym
  • aCML
  • atypical CML
  • atypical chronic myeloid leukaemia
  • atypical chronic myeloid leukaemia BCR-ABL1 negative
  • atypical chronic myeloid leukemia BCR-ABL1 negative
  • subacute myeloid leukemia
Definition
A myelodysplastic myeloproliferative neoplasm characterized by the principal involvement of the neutrophil series with leukocytosis and multilineage dysplasia. The neoplastic cells do not have a Philadelphia chromosome or the BCR/ABL fusion gene.
Super Class
myelodysplastic/myeloproliferative neoplasm
Disease Ontology
DOID:0060597
Mondo Disease Ontology
MeSH
UMLS
NCI Thesaurus
ORDO
Related Genes
Displaying 1 entry
Gene ID Gene Symbol Description Source
2260 FGFR1 fibroblast growth factor receptor 1
Displaying 1 entry
Gene ID Gene Symbol Description Source
14182 Fgfr1 fibroblast growth factor receptor 1
Displaying 1 entry
Gene ID Gene Symbol Description Source
79114 Fgfr1 Fibroblast growth factor receptor 1
Displaying 1 entry
Gene ID Gene Symbol Description Source
42160 htl heartless
Displaying 1 entry
Gene ID Gene Symbol Description Source
30705 fgfr1a fibroblast growth factor receptor 1a
Displaying all 3 entries
Gene ID Gene Symbol Description Source Organism
397782 fgfr1.S fibroblast growth factor receptor 1 S homeolog Xenopus laevis (African clawed frog)
399444 fgfr1.L fibroblast growth factor receptor 1 L homeolog Xenopus laevis (African clawed frog)
548648 fgfr1 fibroblast growth factor receptor 1 Xenopus tropicalis (tropical clawed frog)

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024